WILMINGTON, Mass., Sept. 25, 2014 /PRNewswire/ -- Implant
Sciences Corporation (OTCQB: IMSC), a high technology
supplier of systems and sensors for the homeland security market
and related industries, will host a webcast and conference call on
Monday, September 29, 2014 at
4:15 p.m. to discuss the financial
results for the quarter and fiscal year ended June 30, 2014.
Company Webcast and Conference Call
The Company will host a webcast and conference call on
Monday, September 29, 2014 at
4:15 p.m. Eastern time to review the financial results for the
quarter and fiscal year ended June 30,
2014. Following the Company's prepared remarks there will be
a Q&A session. The call can be accessed by dialing:
800-798-2864 within the U.S. or 617-614-6206 outside the U.S. and
entering passcode 77821278. Participants are asked to
call the assigned number approximately 5 minutes before the
conference call begins. A replay of the conference call
will be available approximately two hours after the call for one
month by dialing: 888-286-8010 within the U.S. or 617-801-6888
outside the U.S. and entering passcode 70417507. The
conference call will also be available live over the Internet at
the "Webcasts" page of the Investor Relations section of Implant
Sciences' website at www.implantsciences.com. A replay
of the webcast will be available for one month after the call.
About Implant Sciences
Implant Sciences is the leader in next generation
Explosives Trace Detection (ETD) technology. In October 2013,
the Company became the third ETD manufacturer, and the sole
American-owned company, to currently have product qualification
from the US Transportation Security Administration. Implant
Sciences develops, manufactures and sells sophisticated sensors and
systems for Security, Safety, and Defense (SS&D) markets. The
Company has developed proprietary technologies used in its
commercial explosives and narcotics trace detection systems, which
ship to a growing number of locations domestically and
internationally. Implant Sciences' QS-H150 portable explosives
trace detector has received Qualified Anti-Terrorism Technology
Designation and, in addition to receiving TSA qualification for
aviation checkpoint and checked baggage and air cargo screening,
certification by Service Technique de l'Aviation Civile in
France for passenger and air cargo
screening, the Company's QS-B220 has also received Qualified
Anti-Terrorism Technology Designation by the U.S. Department of
Homeland Security under the Support Anti-terrorism by Fostering
Effective Technology Act of 2002 (the SAFETY Act). For further
details on the Company and its products, please visit the Company's
website at www.implantsciences.com.
For further information contact:
Implant Sciences
Corporation
Glenn Bolduc, President and
CEO
(978) 752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
SOURCE Implant Sciences Corporation